Source link : https://www.newshealth.biz/health-news/less-than-50-of-accelerated-approvals-show-clinical-benefit/
SAN DIEGO — Fewer than half of the cancer drugs approved under the US Food and Drug Administration’s (FDA’s) accelerated approval pathway between 2013 and 2017 have been shown to improve overall survival or quality of life, despite being on the US market for more than 5 years, according to a new study. Under the […]
Author : News Health
Publish date : 2024-04-08 16:56:05
Copyright for syndicated content belongs to the linked Source.
Categories